Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Smith

Showing results (471-480 of 488) with videos related to

Pageof 49
Sort By:
Nature|April 22, 2022
Author Correction: Metastability of diamond ramp-compressed to 2 terapascalsA Lazicki, D McGonegle, J R Rygg, et al.
NPJ Vaccines|October 15, 2021
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variantsViviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
Vaccine|April 16, 2022
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primatesJewell N Walters, Blake Schouest, Ami Patel, et al.
Physical Review Letters|January 28, 2017
Ultrafast X-Ray Diffraction Studies of the Phase Transitions and Equation of State of Scandium Shock Compressed to 82 GPaR Briggs, M G Gorman, A L Coleman, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Emerging Microbes & Infections|January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primatesAmi Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Cell Reports. Medicine|March 22, 2025
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunityNicholas J Tursi, Sachchidanand Tiwari, Nicole Bedanova, et al.
Cell Reports|November 15, 2018
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse ModelAmi Patel, Daniel H Park, Carl W Davis, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Pageof 49

Showing results (471-480 of 488) with videos related to

Sort By:
Pageof 49
Nature|April 22, 2022
Author Correction: Metastability of diamond ramp-compressed to 2 terapascalsA Lazicki, D McGonegle, J R Rygg, et al.
NPJ Vaccines|October 15, 2021
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variantsViviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
Vaccine|April 16, 2022
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primatesJewell N Walters, Blake Schouest, Ami Patel, et al.
Physical Review Letters|January 28, 2017
Ultrafast X-Ray Diffraction Studies of the Phase Transitions and Equation of State of Scandium Shock Compressed to 82 GPaR Briggs, M G Gorman, A L Coleman, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Emerging Microbes & Infections|January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primatesAmi Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Cell Reports. Medicine|March 22, 2025
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunityNicholas J Tursi, Sachchidanand Tiwari, Nicole Bedanova, et al.
Cell Reports|November 15, 2018
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse ModelAmi Patel, Daniel H Park, Carl W Davis, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Pageof 49